<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>After graduating with his MBBS medical degree from the University of Bombay in Mumbai, India, he completed his Internal Medicine residency in Mumbai. He also completed an internship at LaGuardia Hospital (now Long Island Jewish Forest Hills), as well as his Hematology/Oncology residency and Bone Marrow Transplantation Fellowship at Wayne State University. Following his fellowship, Dr. Gadgeel served as director of the Thoracic Oncology Program and co-leader of Molecular Therapeutics Program at Karmanos Cancer Institute.</p> <p>Prior to Henry Ford, Dr. Gadgeel was a professor in the Department of Internal Medicine and the Mary Lou Kennedy Research Professor in Thoracic Oncology at the University of Michigan/Michigan Medicine.</p> <p>Dr. Gadgeel enhances our academic mission through clinical trials and research, while promoting the growth and expansion of clinical services locally, regionally, and nationally -- further positioning Henry Ford Cancer Institute as a destination and referral center for cancer care. He is the principle investigator on numerous clinical trials, and has published extensively in peer-reviewed literature.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p><strong>Biographical Statement:</strong></p> <p>Dr. Philip Kuriakose attended medical school at Christian Medical College in Ludhiana, India. He completed his post-graduate training at Christian Medical College, Brown Memorial Hospital, and Henry Ford Hospital. Dr. Kuriakose went to the Mayo Graduate School of Medicine in Florida for his fellowship in hematology/oncology.</p> <p>He is a senior staff physician at the Henry Ford Cancer Institute and an assistant professor at Wayne State University Medical School. Dr. Kuriakose specializes in hematology, hemophilia, leukemias, thrombosis, and general cancer care. He is the principal investigator in multiple clinical trials and has published numerous articles on a variety of topics.</p> <p><strong>Care Philosophy:</strong></p> <p>My goal is to provide each patient with wholesome and optimal, individualized care that utilizes the latest medical knowledge and advancements.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p><strong>Biographical Statement:</strong></p> <p>Internationally recognized in the neuro-oncology and precision medicine areas, Dr. Mikkelsen received his MD from the University of Calgary, Canada and completed clinical training in neurology at the Montreal Neurologic Institute. Following this, he did post-doctoral training in brain tumor cellular and molecular biology at the Ludwig Institute for Cancer Research in Montreal and then in La Jolla, California.&nbsp;</p> <p><strong>Philosophy</strong></p> <p>The internet age has been empowering for many patients dealing with a new diagnosis of a brain tumor. However, there is way too much unfiltered content and it takes a real multidisciplinary team to partner with a patient and their family to formulate the best plan of care. We have access to many novel and innovative approaches to treatment to compliment current state-of-the-art treatment. The goal, of course, is to maximize the quality of a person&#39;s life, despite the challenges. This means emotionally, mentally and physically. I pride myself on engaging a patient, the team and moving ahead in the most promising way possible.</p> <p><strong>Research Interests</strong></p> <p>Hermelin Brain Tumor Bank and Personalized Brain Tumor Therapy: HBTC is a leader in the understanding of the genetics of brain tumors, and in the development of therapies matched to each patient&#39;s brain tumor genetics for the best chance at recovery. The Center is a major contributor to The Cancer Genome Atlas (TCGA) - a national cooperative of major academic medical centers sponsored by the National Institutes of Health, responsible for identifying certain survival-related genes. The data generated from the TCGA and the 1000 tumor tissues in the tumor bank are a major resource for each of the HBTC&#39;s research laboratories. HBTC resources constitute some 40% of resources in the national TCGA program.</p> <p>Brain Tumor Neuro-imaging: Dr. Mikkelsen&#39;s laboratory has collaborated extensively with small animal imaging, clinical neuroradiology, and image analysis for pre-clinical and clinical brain tumor studies, primarily using perfusion CT and multiple MRI techniques. The long-term goal is to validate imaging biomarkers as measures of therapeutic response toward targeted therapies.</p> <p>Dr. Mikkelsen works closely with Dr. Tobias Walbert and Dr. Jim Snyder, neuro-oncology colleagues, with clinical research interests focus on outcomes research.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p><strong>Biographical Statement:</strong></p> <p>I specialize in Pancreatic Cancer Surgery, Surgical Oncology and Cytoreductive Cancer Surgery for HIPEC</p> <p>Dr. David Kwon is a board-certified surgeon and fellowship-trained surgical oncologist. He received his undergraduate degree in Biological Sciences from Columbia University and earned his medical degree from the University of California, San Diego. He completed his residency in general surgery at Henry Ford Hospital where he received multiple research and clinical awards. He completed a surgical oncology fellowship at the University of Texas, M.D. Anderson Cancer Center where he developed clinical expertise in the multidisciplinary care of cancer patients.</p> <p>Dr. Kwon&#39;s clinical interests focus on the care and surgical management, including cytoreductive cancer surgery for HIPEC, of patients with upper gastrointestinal malignancies, including gastric, duodenal, biliary, and pancreatic cancers.</p> <p><strong>Care Philosophy:</strong></p> <p>Dr. Kwon specializes in assessment, treatment planning, and surgical services in a multidisciplinary setting. He&rsquo;s dedicated to providing compassionate care for his patients, while perfecting new techniques to improve survival, shorten recovery times and minimize treatment-related side effects. He treats all his patients with the utmost respect and works with them in a supportive and relaxed atmosphere to provide the best possible care.</p> <p><strong>Research Interests:</strong></p> <p>Dr. Kwon&#39;s research is focused on surgical quality of care, outcomes, and racial disparities. He hopes to translate his findings to improve the overall care of cancer patients.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr. Igor Rybkin-Hematologist/oncologist with clinical interests in thoracic oncology, lung cancer, esophageal cancer, mesothelioma, thymoma, chemotherapy, targeted therapy, personalized medicine, clinical trials, malignant tumor, medical oncologist.</p> Read More